BioSpace News Archive

Business

Leyden Labs Aims $140 Million More at Severe Respiratory Infections

Leyden Labs secured $140 million in a Series B financing round. Combined with $40 million from a Series A round in March 2021, the company has significant funding to advance its portfolio of candidates.

January 25, 2022
·
3 min read
·
Alex Keown
Biotech Bay

Money on the Move: January 19 – 25

Temps are falling and so is investor cash. Here’s which biotech companies are scooping up the dollars this week.

January 25, 2022
·
4 min read
·
Kate Goodwin
Business

Herophilus Appoints Brad Savall, Ph.D. as Vice President and Head of Chemistry as it Advances Pipeline of Novel Drugs for Complex Brain Diseases

Herophilus, a leading biotechnology company developing neurotherapeutics to cure complex brain diseases, announced the appointment of Brad Savall, Ph.D. as the company’s new Vice President and Head of Chemistry.

January 25, 2022
·
3 min read
Biotech Beach

IMX-110 + anti-PD-1 Combination Produced Extended Median Survival in Genetic Pancreatic Cancer Mouse Model, Bolstering Planned 2022 IMX-110 Combination Clinical Trial Rationale

Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”), today announced data showing that IMX-110 + anti-PD-1 produced 63-day median survival in a genetic pancreatic cancer mouse model in which mice develop their own pancreatic cancer and have an intact immune system.

January 25, 2022
·
5 min read
BioMidwest

200th Treatment Milestone for AIRFLOW-3 COPD Trial

Nuvaira, a developer of novel therapeutic strategies to treat obstructive lung diseases, announces two treatment milestones.

January 25, 2022
·
3 min read
Quantori Names Pharma IT Veteran Arun Nayar as Global Head of R&D Informatics

New Role Strengthens Quantori’s Global Leadership Position in Data Science & Digital IT.

January 25, 2022
·
3 min read
Cancer Tumor Profiling Market Size to be Worth USD 20.69 Billion Growing at 9.6% CAGR till 2027 | Industry Trend – Increasing demand for personalized medicine and Rise in the adoption of the cancer profiling methods by oncologists

The Cancer Tumor Profiling Market size is expected to reach USD 31.99 Billion by 2027, according to a new report by Emergen Research.

January 25, 2022
·
7 min read
Deep Brain Stimulation Systems Market to be Valued at USD 2,122.8 Million by 2027 | Industry Trend –Potential Investment Opportunities and Favorable Reimbursement Scenario is Expected to Fuel the Market

The global Deep Brain Stimulation (DBS) Systems Market size was valued at USD 1227.5 million in 2019 and is expected to reach USD 2,122.8 million by 2027, at a CAGR of 8.1% according to a new report by Emergen Research.

January 25, 2022
·
7 min read
Molecular Diagnostics Point of Care Market to be Valued at USD 4.84 Billion by 2027 | Industry Trend – High demand for point-of-care diagnostics

The Global Molecular Diagnostics Point of Care Market is projected to reach USD 4.84 billion in 2027.

January 25, 2022
·
7 min read
Precision Medicine Market Size to be Worth USD 132.66 Billion by 2027 | Industry Trend – High incidence of cancer

The global Precision Medicine Market is expected to reach USD 132.66 Billion by 2027, according to a new report by Emergen Research.

January 25, 2022
·
6 min read